← All Envoy Medical, INC filings

Envoy Medical, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
COCH
Envoy Medical, INC
SCHEDULE: Bleichroeder Discloses 9.99% Stake in Envoy Medical
Investment firm Bleichroeder LP reports a 9.99% beneficial ownership stake in Envoy Medical, Inc. through common stock and warrants.
NASDAQ
COCH
Envoy Medical, INC
SCHEDULE: Ayrton Capital Discloses 3.1% Stake in Envoy Medical
Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri have filed a Schedule 13G reporting a 3.1% beneficial ownership stake in Envoy Medical, Inc. through warrant holdings.
NASDAQ
COCH
Envoy Medical, INC
SCHEDULE: Ayrton Capital, Alto Fund Disclose 7.87% Stake in Envoy Medical
Ayrton Capital LLC, Alto Opportunity Master Fund, SPC, and Waqas Khatri have jointly disclosed a 7.87% beneficial ownership stake in Envoy Medical, Inc. through warrants.
NASDAQ
COCH
Envoy Medical, INC
SCHEDULE: Alta Partners Discloses 8.25% Stake in Envoy Medical
Alta Partners LLC has disclosed a passive 8.25% beneficial ownership stake in Envoy Medical, Inc.'s Class A Common Stock.
NASDAQ
COCH
Envoy Medical, INC
SCHEDULE 13G/A: Aristeia Capital Reduces Stake in Envoy Medical Warrants Below 5%
Aristeia Capital, L.L.C. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 4.74% in Envoy Medical, Inc.'s redeemable warrants, indicating a reduction from a previously reportable stake.
NASDAQ
COCH
Envoy Medical, INC
SCHEDULE 13G/A: Walleye Capital LLC Discloses 2.72% Beneficial Ownership in Envoy Medical Warrants
Walleye Capital LLC has filed an amended Schedule 13G, reporting a 2.72% beneficial ownership stake in Envoy Medical, Inc.'s redeemable warrants as of December 31, 2024.